Ret Proto-Oncogene anticorps (AA 713-1017)
RET
Reactivité: Humain
WB, IHC
Hôte: Souris
Monoclonal
OTI5C5
unconjugated
N° du produit ABIN2730736
-
-
Antigène
Voir toutes Ret Proto-Oncogene (RET) Anticorps
-
Ret Proto-Oncogene (RET)
-
Épitope
-
AA 713-1017
-
Reactivité
-
Humain
-
Hôte
-
Souris
-
Clonalité
-
Monoclonal
-
Conjugué
-
Cet anticorp Ret Proto-Oncogene est non-conjugé
-
Application
-
Western Blotting (WB), Immunohistochemistry (IHC)
-
Purification
-
Purified from mouse ascites fluids by affinity chromatography
-
Immunogène
-
Human recombinant protein fragment corresponding to amino acids 713-1017 of human RET(NP_066124) produced in E.coli.
-
Clone
-
OTI5C5
-
Isotype
-
IgG1
-
Top Product
-
Discover our top product RET Anticorps primaire
-
-
-
Indications d'application
-
WB 1:2000, IHC 1:150,
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Concentration
-
1 mg/mL
-
-
Antigène
-
Ret Proto-Oncogene (RET)
-
Autre désignation
-
RET (RET Produits)
-
Synonymes
-
anticorps c-ret, anticorps cret, anticorps etID315074.13, anticorps ret1, anticorps wu:fd13h01, anticorps X-ret, anticorps ret-A, anticorps xret, anticorps RET, anticorps MTC1, anticorps CDHF12, anticorps CDHR16, anticorps HSCR1, anticorps MEN2A, anticorps MEN2B, anticorps PTC, anticorps RET-ELE1, anticorps RET51, anticorps RET9, anticorps c-Ret, anticorps ret proto-oncogene receptor tyrosine kinase, anticorps ret proto-oncogene S homeolog, anticorps ret proto-oncogene, anticorps ret, anticorps ret.S, anticorps RET, anticorps Ret
-
Poids moléculaire
-
124.1 kDa
-
NCBI Accession
-
NM_020975
-
HGNC
-
5979
-
Pathways
-
Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
-